Go Pro
→ How options let you do more with less capital (From Base Camp Trading) (Ad)tc pixel Free TARA Stock Alerts

Protara Therapeutics (TARA) Short Interest Ratio & Short Volume

Protara Therapeutics logo
$2.70 -0.06 (-2.17%)
Closing price 04:00 PM Eastern
Extended Trading
$2.78 +0.08 (+2.93%)
As of 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Protara Therapeutics Short Interest Overview

As of September 15, 2026, Protara Therapeutics (TARA) had a short interest of 4.42 million shares sold short, representing 8.09% of the public float. This marks a -0.34% decrease in short interest since the prior report. The short interest ratio (days to cover) is 10.3, meaning it would take 10.3 days of the average trading volume of 878,943 shares to cover all short positions.

Current Short Interest
4,417,095 shares
Previous Short Interest
4,431,963 shares
Change Vs. Previous Month
-0.34%
Dollar Volume Sold Short
$16.56 million
Short Interest Ratio
10.3 Days to Cover
Last Record Date
September 15, 2026
Outstanding Shares
59,100,000 shares
Short Percent of Float
8.09%
Today's Trading Volume
1,909,075 shares
Average Trading Volume
878,943 shares
Today's Volume Vs. Average
217%
Short Selling Protara Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Protara Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

TARA Short Interest Over Time

TARA Days to Cover Over Time

TARA Percentage of Float Shorted Over Time

Protara Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/20264,417,095 shares $16.56 million -0.3%8.1%10.34 $3.75
8/31/20264,431,963 shares $17.11 million -2.4%8.1%12.36 $3.86
8/14/20264,541,333 shares $18.03 million +1.0%8.3%12.03 $3.97
7/31/20264,495,001 shares $17.62 million -1.0%8.7%11.47 $3.92
7/15/20264,541,891 shares $18.71 million +4.8%8.7%6.72 $4.12
6/30/20264,335,683 shares $16.56 million -2.9%8.3%5.12 $3.82
6/15/20264,465,466 shares $17.59 million -24.2%8.6%6.55 $3.94
5/29/20265,888,171 shares $27.38 million +57.5%11.3%6.17 $4.65
5/15/20263,739,353 shares $19.07 million -37.6%7.2%5.61 $5.10
4/30/20265,995,936 shares $31.96 million +4.4%11.8%9.57 $5.33
4/15/20265,745,340 shares $29.93 million +3.5%11.1%11.15 $5.21
3/31/20265,550,159 shares $28.92 million -13.3%10.7%6.14 $5.21
3/13/20266,399,060 shares $33.66 million +30.7%13.5%6.19 $5.26
2/27/20264,895,488 shares $31.14 million +48.0%10.8%3.08 $6.36
2/13/20263,308,046 shares $21.54 million +16.8%6.4%6.15 $6.51
1/30/20262,832,933 shares $20.06 million +12.3%6.3%2.34 $7.08
1/15/20262,521,732 shares $12.71 million +14.7%5.6%2.06 $5.04
12/31/20252,198,324 shares $11.72 million -15.5%4.9%3.95 $5.33
12/15/20252,602,314 shares $14.31 million -10.5%5.8%1.68 $5.50
11/28/20252,908,827 shares $21.45 million +4.8%8.6%3.12 $7.37
11/14/20252,774,733 shares $15.29 million -1.8%7.9%6.51 $5.51
10/31/20252,825,459 shares $14.64 million -1.0%8.0%8.27 $5.18
10/15/20252,860,000 shares $16.36 million +16.3%8.5%7 $5.72
9/30/20252,460,000 shares $10.70 million -8.6%N/A6.7 $4.35
9/15/20252,690,000 shares $8.50 million -10.0%N/A7.5 $3.16
8/31/20252,990,000 shares $9.33 million +7.9%8.5%10.8 $3.12
8/15/20252,770,000 shares $8.39 million -5.5%N/A9.3 $3.03
7/31/20252,930,000 shares $9.08 million +1.4%8.3%9.1 $3.10
7/15/20252,890,000 shares $8.81 million +2.1%N/A7.1 $3.05
6/30/20252,830,000 shares $8.57 million +28.6%8.0%6.5 $3.03
6/15/20252,200,000 shares $6.91 million +0.9%6.2%6.3 $3.14
5/31/20252,180,000 shares $6.71 million -3.1%12.1%6.2 $3.08
5/15/20252,250,000 shares $7.00 million -9.3%12.5%6.2 $3.11
4/30/20252,480,000 shares $8.68 million +22.2%N/A7 $3.50
4/15/20252,030,000 shares $8.47 million -2.4%11.2%6.8 $4.17
3/31/20252,080,000 shares $8.86 million +16.9%11.5%7.3 $4.26
3/15/20251,780,000 shares $7.67 million -40.1%9.9%5.1 $4.31
2/28/20252,970,000 shares $11.11 million -28.4%16.5%1.3 $3.74
2/15/20254,150,000 shares $17.26 million -1.2%23.0%1.8 $4.16
1/31/20254,200,000 shares $20.66 million -4.6%N/A1.8 $4.92
How options let you do more with less capital (Ad)

Would you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fraction of the cost? That's the core advantage options offer traders at every level. The Beginner's Guide to Options breaks down leverage, income strategies, and real trade examples in plain English — including a little-known approach many traders use to reduce costs and improve profit potential. Download your free copy before this offer expires.tc pixel

Claim your free copy of The Beginner's Guide to Options now
1/15/20254,400,000 shares $20.55 million -13.7%N/A1.9 $4.67
12/31/20245,100,000 shares $26.93 million -5.7%N/A2.3 $5.28
12/15/20245,410,000 shares $32.35 million +79.1%N/A2.5 $5.98
11/30/20243,020,000 shares $9.09 million +10.6%N/A1.5 $3.01
11/15/20242,730,000 shares $6.74 million -0.4%N/A16.2 $2.47
10/31/20242,740,000 shares $6.88 million +18.1%N/A15.3 $2.51
10/15/20242,320,000 shares $4.15 million +7.9%N/A14.2 $1.79
9/30/20242,150,000 shares $3.93 million +2.4%N/A13.7 $1.83
9/15/20242,100,000 shares $3.95 million +2.4%N/A12.9 $1.88
8/31/20242,050,000 shares $4.10 million +9.0%N/A12.3 $2.00
8/15/20241,880,000 shares $3.85 million +8.1%N/A10.7 $2.05
7/31/20241,740,000 shares $3.88 million -3.3%N/A6.9 $2.23
7/15/20241,800,000 shares $4.28 million +1.7%N/A6.3 $2.38
6/30/20241,770,000 shares $3.68 million +2.9%N/A5.9 $2.08
6/15/20241,720,000 shares $4.42 million +8.9%N/A4.2 $2.57
5/31/20241,580,000 shares $4.44 million +16.2%N/A4 $2.81
5/15/20241,360,000 shares $5.05 million +32.0%N/A3.6 $3.71
4/30/20241,030,000 shares $3.07 million +158.6%N/A3.5 $2.98
4/15/2024398,300 shares $1.13 million +510.9%4.4%1.6 $2.84
3/31/202465,200 shares $261.45 thousand +6.2%0.7%0.3 $4.01
3/15/202461,400 shares $225.95 thousand -22.3%0.7%0.8 $3.68
2/29/202479,000 shares $360.24 thousand +33.9%0.9%1.1 $4.56
2/15/202459,000 shares $208.27 thousand -33.0%0.7%0.8 $3.53
1/31/202488,100 shares $224.66 thousand +19.2%1.1%1.5 $2.55
1/15/202473,900 shares $170.71 thousand +1.5%0.9%1.3 $2.31
12/31/202372,800 shares $136.51 thousand +46.8%0.9%1.3 $1.88
12/15/202349,600 shares $88.29 thousand -16.2%0.6%1.1 $1.78
11/30/202359,200 shares $85.84 thousand +22.3%0.7%1.6 $1.45
11/15/202348,400 shares $58.08 thousand +1.7%0.6%1.6 $1.20
10/31/202347,600 shares $59.27 thousand -3.3%0.6%1.9 $1.25
10/15/202349,200 shares $81.18 thousand -4.3%0.6%2.5 $1.65
9/30/202351,400 shares $85.84 thousand +5.5%0.6%2.2 $1.67
9/15/202348,700 shares $90.10 thousand -7.4%0.6%1.8 $1.85
8/31/202352,600 shares $114.67 thousand +14.4%0.6%1.8 $2.18
8/15/202346,000 shares $109.02 thousand -40.8%0.6%1.4 $2.37
7/31/202377,700 shares $201.24 thousand -28.5%0.9%2.3 $2.59
7/15/2023108,600 shares $298.65 thousand +10.0%1.3%2.9 $2.75
6/30/202398,700 shares $235.89 thousand -9.0%1.2%2.7 $2.39
6/15/2023108,400 shares $308.94 thousand +11.0%1.3%3.2 $2.85
5/31/202397,700 shares $272.58 thousand +0.2%1.2%2.7 $2.79
5/15/202397,500 shares $328.58 thousand -4.6%1.2%2.6 $3.37
4/30/2023102,200 shares $322.95 thousand +34.1%1.2%3.2 $3.16
4/15/202376,200 shares $221.74 thousand -0.4%0.9%2.4 $2.91
3/31/202376,500 shares $239.45 thousand -0.4%0.9%3.2 $3.13
3/15/202376,800 shares $235.78 thousand -0.9%0.9%3.2 $3.07
2/28/202377,500 shares $273.58 thousand -5.8%0.9%4.2 $3.53
2/15/202382,300 shares $264.18 thousand -2.4%0.9%4.5 $3.21
1/31/202384,300 shares $275.24 thousand -0.6%1.0%3.5 $3.27
1/15/202384,800 shares $284.93 thousand -1.5%1.0%3.2 $3.36
12/30/202286,100 shares $230.75 thousand +8.4%1.0%3 $2.68
Major Buy Alert Issued for October 31st (Ad)

Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide. His system has flagged a handful of stocks worth watching ahead of October 31st. See which stocks his AI research platform is flagging right now.tc pixel

See which stocks his AI research platform is flagging now
12/15/202279,400 shares $243.76 thousand -30.8%0.9%2.5 $3.07
11/30/2022114,700 shares $404.89 thousand +22.7%1.3%3 $3.53
11/15/202293,500 shares $276.76 thousand +7.5%1.0%2.2 $2.96
10/31/202287,000 shares $267.09 thousand +2.7%1.0%2 $3.07
10/15/202284,700 shares $281.20 thousand -16.6%1.0%2.1 $3.32
9/30/2022101,600 shares $300.74 thousand -9.5%1.2%2.8 $2.96
9/15/2022112,200 shares $433.09 thousand +14.5%1.3%2.6 $3.86
8/31/202298,000 shares $338.10 thousand +9.0%1.2%2.3 $3.45
8/15/202289,900 shares $311.95 thousand -1.0%1.1%2.4 $3.47
7/31/202290,800 shares $271.49 thousand -32.7%1.1%2.4 $2.99
7/15/2022135,000 shares $422.55 thousand +32.1%1.6%3.6 $3.13
6/30/2022102,200 shares $299.45 thousand -32.4%1.2%2.7 $2.93
6/15/2022151,200 shares $471.74 thousand -5.0%1.8%4.7 $3.12
5/31/2022159,200 shares $531.73 thousand +5.5%1.9%5.6 $3.34
5/15/2022150,900 shares $436.10 thousand +1.6%1.8%4.9 $2.89
4/30/2022148,500 shares $543.51 thousand -6.8%1.8%4.9 $3.66
4/15/2022159,400 shares $730.05 thousand -15.5%1.9%4.8 $4.58
3/31/2022188,700 shares $964.26 thousand -8.0%2.2%5 $5.11
3/15/2022205,100 shares $916.80 thousand -30.4%2.4%3.9 $4.47
2/28/2022294,500 shares $1.36 million +17.9%3.5%5.1 $4.63
2/15/2022249,900 shares $1.31 million -10.3%3.0%4 $5.25
1/31/2022278,500 shares $1.45 million -8.3%3.2%3.7 $5.21
1/15/2022303,700 shares $1.93 million -19.8%3.4%3.5 $6.37
12/31/2021378,600 shares $2.56 million -3.1%4.2%1.2 $6.75
12/15/2021390,700 shares $2.56 million +32.3%4.3%1.3 $6.56
11/30/2021295,300 shares $2.03 million -7.4%3.2%0.9 $6.89
11/15/2021318,800 shares $2.28 million -11.4%3.5%1 $7.15
10/29/2021359,600 shares $2.49 million -20.7%4.0%1.1 $6.92
10/15/2021453,400 shares $3.10 million +249.9%5.0%1.4 $6.84

TARA Short Interest - Frequently Asked Questions

Short interest is the volume of Protara Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 4,417,095 shares of TARA short. 8.09% of Protara Therapeutics' shares are currently sold short. Learn More on Protara Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARA shares currently have a short interest ratio of 10.3. Learn More on Protara Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.09% of Protara Therapeutics' floating shares are currently sold short.

Protara Therapeutics saw a decline in short interest in September. As of September 15th, there was short interest totaling 4,417,095 shares, a decline of 0.3% from the previous total of 4,431,963 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

8.09% of Protara Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Protara Therapeutics: Olema Pharmaceuticals, Inc. (21.00%), Design Therapeutics, Inc. (10.53%), WAVE Life Sciences Ltd. (11.82%), Pharming Group N.V. Sponsored ADR (0.03%), DBV Technologies S.A. (2.18%), Sensei Biotherapeutics, Inc. (5.49%), Aclaris Therapeutics, Inc. (12.08%), Verastem, Inc. (20.30%), Annexon, Inc. (19.33%), Ironwood Pharmaceuticals, Inc. (12.50%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.21 billion), Invesco QQQ ($46.31 billion), iShares Russell 2000 ETF ($27.98 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($9.70 billion), Canadian Natural Resources Limited ($9.42 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($8.53 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.79 billion), and Financial Select Sector SPDR Fund ($7.74 billion). View all of the most shorted stocks.

Short selling TARA is an investing strategy that aims to generate trading profit from Protara Therapeutics as its price is falling. TARA shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Protara Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TARA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARA, twice per month. The most recent reporting period available is September, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like TARA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:TARA is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/24/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Elon Warns "America Will Go Bankrupt". Trump's Plan Inside.
National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...
American Hartford Gold | Sponsoredtc pixel
MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altuche...
Paradigm Press | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
A new kind of civil war is coming after election day?
Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the politic...
Stansberry Research | Sponsoredtc pixel
How Elon’s Empire Ends (and how to profit)
Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...
Chaikin Analytics | Sponsoredtc pixel
How options let you do more with less capital
Would you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...
Base Camp Trading | Sponsoredtc pixel
Major Buy Alert Issued for October 31st
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel